Literature DB >> 17617044

Proposal of a candidate international conventional reference measurement procedure for free thyroxine in serum.

Linda M Thienpont, Graham Beastall, Nicholas D Christofides, James D Faix, Tamio Ieiri, Véronique Jarrige, W Greg Miller, Richard Miller, Jerald C Nelson, Cathérine Ronin, H Alec Ross, Michael Rottmann, Jos H Thijssen, Brigitte Toussaint.   

Abstract

In the present paper the IFCC WG-STFT recommends and provides the rationale to establish metrological traceability of serum free thyroxine (FT4) measurements to a candidate international conventional reference measurement procedure. It is proposed that this procedure be based on equilibrium dialysis combined with determination of thyroxine in the dialysate with a trueness-based reference measurement procedure. The measurand is thus operationally defined as "thyroxine in the dialysate from equilibrium dialysis of serum prepared under defined conditions". With regard to the trueness-based reference measurement procedure, the WG-STFT recommends use of an isotope dilution-liquid chromatography/tandem mass spectrometry (ID-LC/tandem MS) procedure for total thyroxine that has been optimized towards measurement at picomolar concentration levels and that is listed in the database of the Joint Committee for Traceability in Laboratory Medicine (JCTLM). For calibration, the purified thyroxine material IRMM-468 (resulting from a project funded by the European Commission and recently submitted to the JCTLM) is proposed. The WG-STFT stresses that according to this recommendation it is a prerequisite to strictly adhere to the defined equilibrium dialysis procedure, whereas it is permissible to introduce variants in the ID-LC/tandem MS procedure.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17617044     DOI: 10.1515/CCLM.2007.155

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  8 in total

1.  Standardization of Free T4 and Harmonization of TSH Measurements: A Request for Input from Endocrinologists and Other Physicians.

Authors:  Linda M Thienpont; James D Faix; Graham Beastall
Journal:  Eur Thyroid J       Date:  2015-10-06

2.  When thyroidologists agree to disagree: comments on the 2012 Endocrine Society pregnancy and thyroid disease clinical practice guideline.

Authors:  Offie P Soldin
Journal:  J Clin Endocrinol Metab       Date:  2012-08       Impact factor: 5.958

Review 3.  Biochemical Testing of the Thyroid: TSH is the Best and, Oftentimes, Only Test Needed - A Review for Primary Care.

Authors:  Michael T Sheehan
Journal:  Clin Med Res       Date:  2016-05-26

Review 4.  Thyroid hormone testing by tandem mass spectrometry.

Authors:  Offie P Soldin; Steven J Soldin
Journal:  Clin Biochem       Date:  2010-08-04       Impact factor: 3.281

5.  TSH - Clinical Aspects of its Use in Determining Thyroid Disease in the Elderly. How Does it Impact the Practice of Medicine in Aging?

Authors:  Mackenzie Deary; Timothy Buckey; Offie P Soldin
Journal:  Adv Pharmacoepidemiol Drug Saf       Date:  2012-10-29

6.  Doubts and Concerns about Isolated Maternal Hypothyroxinemia.

Authors:  Mariacarla Moleti; Francesco Trimarchi; Francesco Vermiglio
Journal:  J Thyroid Res       Date:  2011-06-15

7.  Reference Intervals of Thyroid Function Tests Assessed by Immunoassay and Mass Spectrometry in Healthy Pregnant Women Living in Catalonia.

Authors:  José María Hernández; Berta Soldevila; Inés Velasco; Fernando Moreno-Flores; Laura Ferrer; Alejandra Pérez-Montes de Oca; Cecilia Santillán; Carla Muñoz; Sílvia Ballesta; Cristina Canal; Manel Puig-Domingo; María Luisa Granada
Journal:  J Clin Med       Date:  2021-05-31       Impact factor: 4.241

8.  The Use of TSH in Determining Thyroid Disease: How Does It Impact the Practice of Medicine in Pregnancy?

Authors:  Offie P Soldin; Sarah H Chung; Christine Colie
Journal:  J Thyroid Res       Date:  2013-05-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.